Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis

Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host–pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis

Mycobacterium africanum comprises two phylogenetic lineages within the Mycobacterium tuberculosis complex (MTBC). M. africanum was first described and isolated in 1968 from the sputum of a Senegalese patient with pulmonary tuberculosis (TB) and it has been identified increasingly as an important cau...

Full description

Bibliographic Details
Main Authors: Alimuddin Zumla, Isaac Darko Otchere, Gloria Ivy Mensah, Adwoa Asante-Poku, Florian Gehre, Markus Maeurer, Matthew Bates, Peter Mwaba, Francine Ntoumi, Dorothy Yeboah-Manu
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:International Journal of Infectious Diseases
Subjects:
TB
Mycobacterium africanum
Mycobacterium tuberculosis complex
Host
Diagnostics
Vaccines
Africa
EDCTP
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971216316460

Internet

http://www.sciencedirect.com/science/article/pii/S1201971216316460

Similar Items